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items might not apply to an individual manuscript, but all fields must be completed for clarity. 
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`    Experimental design
1.   Sample size
Describe how sample size was determined. No statistical methods were used to pre-determine the sample size, but the sample 
size used in this study (n = 23) is comparable with previous fMRI studies using a 
similar paradigm (e.g., McNamee et al., Nat. Neuro, 2013; and Chib et al., JNS, 
2009).
2.   Data exclusions
Describe any data exclusions. The data from one participant was excluded due to technical problems with the 
fMRI scanning.
3.   Replication
Describe whether the experimental findings were 
reliably reproduced.
The value signals reported in the present manuscript have been reported in many 
previous studies. The findings about nutritive attributes were confirmed using 
multiple analytical approaches on the same data-set, showing robustness of our 
findings to different analytical methods. We have not re-run the study with 
another independent set of participants.
4.   Randomization
Describe how samples/organisms/participants were 
allocated into experimental groups.
In each of the run 1 and 3, randomly selected 28 out of the 56 food items were 
presented twice in random order (i.e., 56 trials for each run). The other 28 food 
items were presented twice in each of the run 2 and 4.
5.   Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
No group allocation was used, and the investigators were not blinded to the 
conditions within participants -- it is not feasible to do so within the context of this 
experimental design. 
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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6.   Statistical parameters 
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the 
Methods section if additional space is needed). 
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
`   Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this 
study. 
We used publicly available softwares: Psychtoolbox for stimulus presentations; and 
Matlab R2013b, SPM8 and The Decoding Toolbox (Hebart et al., 2015) for data 
analyses.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
`   Materials and reagents
Policy information about availability of materials
8.   Materials availability
Indicate whether there are restrictions on availability of 
unique materials or if these materials are only available 
for distribution by a for-profit company.
N/A
9.   Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
N/A
10. Eukaryotic cell lines
a.  State the source of each eukaryotic cell line used. N/A
b.  Describe the method of cell line authentication used. Describe the authentication procedures for each cell line used OR declare that none 
of the cell lines used have been authenticated OR state that no eukaryotic cell lines 
were used.
c.  Report whether the cell lines were tested for 
mycoplasma contamination.
Confirm that all cell lines tested negative for mycoplasma contamination OR 
describe the results of the testing for mycoplasma contamination OR declare that 
the cell lines were not tested for mycoplasma contamination OR state that no 
eukaryotic cell lines were used.
d.  If any of the cell lines used are listed in the database 
of commonly misidentified cell lines maintained by 
ICLAC, provide a scientific rationale for their use.
Provide a rationale for the use of commonly misidentified cell lines OR state that no 
commonly misidentified cell lines were used.
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`    Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived 
materials used in the study.
N/A
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population 
characteristics of the human research participants.
We used the data from 23 participants (8 females; age, 30.7 ± 4.12 years, MEAN ± 
SD; and BMI, 23.51 ± 4.00, MEAN ± SD). All the participants were preassessed to 
exclude those with any previous history of neurological/psychiatric illness. We also 
confirmed that the participants were not on a diet or seeking to lose weight for any 
reason.
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 Form fields will expand as needed. Please do not leave fields blank.
`    Experimental design
1.   Describe the experimental design. Task; event-related design
2.   Specify the number of blocks, trials or experimental 
units per session and/or subject, and specify the 
length of each trial or block (if trials are blocked) 
and interval between trials.
The task consists of 4 fMRI runs of the 56 trials (each trial takes 12s on 
average; and intervals between trials are jittered (2-12s)).
3.   Describe how behavioral performance was 
measured.
Subjective values for food items were recorded.
`    Acquisition
4.   Imaging
a. Specify the type(s) of imaging. Functional
b. Specify the field strength (in Tesla). 3T
c. Provide the essential sequence imaging parameters. We used a one-shot T2*-weighted echo planar imaging sequence (Volume 
TR = 2780 ms, TE = 30 ms, FA = 80°). 44 oblique slices (thickness = 3.0 mm, 
gap = 0 mm, FOV = 192 × 192 mm, matrix = 64 × 64) were acquired per 
volume. The slices were aligned 30° to the AC–PC plane to reduce signal 
dropout in the orbitofrontal area.
d. For diffusion MRI, provide full details of imaging 
parameters.
N/A
5.   State area of acquisition. Whole-brain
`    Preprocessing
6.   Describe the software used for preprocessing. SPM8 on MATLAB R2013b
7.   Normalization
a. If data were normalized/standardized, describe the 
approach(es).
The standard procedure with segmentation in SPM8 was used.
b. Describe the template used for normalization/
transformation.
MNI template
8.   Describe your procedure for artifact and structured 
noise removal.
Motion-correction parameters were included into the GLM.
9.   Define your software and/or method and criteria 
for volume censoring, and state the extent of such 
censoring.
We discarded volumes recorded at 10 sec and later from the end of the 
last trial in each run.
`    Statistical modeling & inference
10. Define your model type and settings. Multi-voxel pattern analysis at the first-level; and random-effect analysis at 
the second-level
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11. Specify the precise effect tested. Mean value of the decoding accuracies over the participants
12. Analysis
a. Specify whether analysis is whole brain or ROI-based. We employed both whole-brain and ROI-based analyses.
b. If ROI-based, describe how anatomical locations were 
determined.
We used AAL database (Tzourio-Mazoyer et al., 2002).
13. State the statistic type for inference. 
(See Eklund et al. 2016.)
For the whole-brain analysis, we employed a cluster-level correction for 
multiple comparisons implemented in SPM8 (cluster-forming threshold P = 
0.001).
14. Describe the type of correction and how it is 
obtained for multiple comparisons.
FWE
15. Connectivity
a. For functional and/or effective connectivity, report the 
measures of dependence used and the model details.
Regression coefficient of the psycho-physiological Interaction term.
b. For graph analysis, report the dependent variable and 
functional connectivity measure.
N/A
16. For multivariate modeling and predictive analysis, 
specify independent variables, features extraction 
and dimension reduction, model, training and 
evaluation metrics.
Independent variables (classification samples) were voxel-wise fMRI 
responses to each food item; and the classification accuracy was evaluated 
by leave-one-run-out cross-validation.
